Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine
- PMID: 17372697
- DOI: 10.1007/s11095-006-9191-2
Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine
Abstract
Objectives: To investigate the impact of drying method on the storage stability of dried vaccine formulations.
Materials and methods: A sucrose-based formulation of a live attenuated virus vaccine of a parainfluenza strain, with and without surfactant, was dried from by different methods; freeze drying, spray drying and foam drying. Dried powders were characterized by differential scanning calorimetry, specific surface area (SSA) analysis and by electron spectroscopy for chemical analysis (ESCA) to evaluate vaccine surface coverage in the dried formulations. Dried formulations were subjected to storage stability studies at 4, 25 and 37 degrees C. The vaccine was assayed initially and at different time points to measure virus-cell infectivity, and the degradation rate constant of the vaccine in different dried preparations was determined.
Results: SSA was highest with the spray dried preparation without surfactant (approximately 2.8 m(2)/g) and lowest in the foam dried preparations (with or without surfactant) (approximately 0.1 m(2)/g). Vaccine surface coverage was estimated based on ESCA measurements of nitrogen content. It was predicted to be highest in the spray dried preparation without surfactant and lowest in the foam with surfactant. Stability studies conducted at 25 degrees C and 37 degrees C showed that the vaccine was most stable in the foam dried preparation with surfactant and least stable in spray dried preparations without surfactant and in all freeze dried preparations regardless of the presence of surfactant. Addition of surfactant did lower the SSA and vaccine surface coverage in freeze dried preparations but still did not improve storage stability.
Conclusions: In drying methods that did not involve a freezing step, good storage stability of Medi 534 vaccine in the dried form was found with low SSA and low vaccine surface accumulation, both of which integrate into low fraction of vaccine at the surface. Ice appears to be a major destabilizing influence.
Similar articles
-
Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.J Pharm Sci. 2007 Aug;96(8):1983-2008. doi: 10.1002/jps.20859. J Pharm Sci. 2007. PMID: 17286290
-
The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.J Pharm Sci. 2008 Jan;97(1):163-84. doi: 10.1002/jps.21085. J Pharm Sci. 2008. PMID: 17722086
-
Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.Pharm Res. 2016 May;33(5):1144-60. doi: 10.1007/s11095-016-1860-1. Epub 2016 Jan 27. Pharm Res. 2016. PMID: 26818839
-
Developments in the formulation and delivery of spray dried vaccines.Hum Vaccin Immunother. 2017 Oct 3;13(10):2364-2378. doi: 10.1080/21645515.2017.1356952. Hum Vaccin Immunother. 2017. PMID: 28925794 Free PMC article. Review.
-
Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.Adv Exp Med Biol. 2018;1081:371-383. doi: 10.1007/978-981-13-1244-1_20. Adv Exp Med Biol. 2018. PMID: 30288720 Review.
Cited by
-
Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.Pharm Res. 2008 Oct;25(10):2250-61. doi: 10.1007/s11095-008-9613-4. Epub 2008 Jun 27. Pharm Res. 2008. PMID: 18584311
-
Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface.Eur J Pharm Biopharm. 2014 Oct;88(2):332-41. doi: 10.1016/j.ejpb.2014.05.012. Epub 2014 May 21. Eur J Pharm Biopharm. 2014. PMID: 24859390 Free PMC article.
-
Thermostable vacuum foam dried Newcastle disease vaccine: Process optimization and pilot-scale study.Appl Microbiol Biotechnol. 2024 Jun 5;108(1):359. doi: 10.1007/s00253-024-13174-7. Appl Microbiol Biotechnol. 2024. PMID: 38836885 Free PMC article.
-
Development of stable influenza vaccine powder formulations: challenges and possibilities.Pharm Res. 2008 Jun;25(6):1256-73. doi: 10.1007/s11095-008-9559-6. Pharm Res. 2008. PMID: 18338241 Free PMC article. Review.
-
Effects of glycosylation on the stability of protein pharmaceuticals.J Pharm Sci. 2009 Apr;98(4):1223-45. doi: 10.1002/jps.21504. J Pharm Sci. 2009. PMID: 18661536 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials